Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
Introduction. Various pain management strategies for patients undergoing open excisional hemorrhoidectomy have been proposed, yet postoperative pain remains a frequent complaint. Objective. To determine whether mesoglycan (30 mg two vials i.m. once/day for the first 5 days postoperative, followed by...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/6423895 |
id |
doaj-77732bb08f194734b0b8c5706dd9a41a |
---|---|
record_format |
Article |
spelling |
doaj-77732bb08f194734b0b8c5706dd9a41a2020-11-24T22:37:41ZengHindawi LimitedGastroenterology Research and Practice1687-61211687-630X2018-01-01201810.1155/2018/64238956423895Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter StudyGaetano Gallo0Massimiliano Mistrangelo1Roberto Passera2Valentina Testa3Mauro Pozzo4Roberto Perinotti5Ivan Lanati6Ivano Lazzari7Paolo Tonello8Elettra Ugliono9Emilia De Luca10Alberto Realis Luc11Giuseppe Clerico12Mario Trompetto13Department of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyDepartment of Surgical Science, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyNuclear Medicine Department, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyDepartment of Surgical Science, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyColorectal Surgical Unit, Department of Surgery, Infermi Hospital, Biella, ItalyColorectal Surgical Unit, Department of Surgery, Infermi Hospital, Biella, ItalyDepartment of Surgery, Savigliano Hospital, Savigliano, ItalyDepartment of Surgery, Savigliano Hospital, Savigliano, ItalyDepartment of Surgery, Koelliker Hospital, Turin, ItalyDepartment of Surgical Science, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyDepartment of Surgical and Medical Sciences, University “Magna Graecia” of Catanzaro, Catanzaro, ItalyDepartment of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyDepartment of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyDepartment of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyIntroduction. Various pain management strategies for patients undergoing open excisional hemorrhoidectomy have been proposed, yet postoperative pain remains a frequent complaint. Objective. To determine whether mesoglycan (30 mg two vials i.m. once/day for the first 5 days postoperative, followed by 50 mg 1 oral tablet twice/day for 30 days) would reduce the edema of the mucocutaneous bridges and thus improve postoperative pain symptoms. Patients and Methods. For this prospective observational multicenter study, 101 patients undergoing excisional diathermy hemorrhoidectomy for III-IV degree hemorrhoidal disease were enrolled at 5 colorectal referral centers. Patients were assigned to receive either mesoglycan (study group SG) or a recommended oral dose of ketorolac tromethamine of 10 mg every 4–6 hours, not exceeding 40 mg per day and not exceeding 5 postoperative days according to the indications for short-term management of moderate/severe acute postoperative pain, plus stool softeners (control group CG). Results. Postoperative thrombosis (SG 1/48 versus CG 5/45) (p<0.001) and pain after rectal examination (p<0.001) were significantly reduced at 7–10 days after surgery in the mesoglycan-treated group, permitting a faster return to work (p<0.001); however, in the same group, the incidence of postoperative bleeding, considered relevant when needing a readmission or an unexpected outpatient visit, was higher, possibly owing to the drug’s antithrombotic properties. Conclusions. The administration of mesoglycan after an open diathermy excisional hemorrhoidectomy can reduce postoperative thrombosis and pain at 7–10 days after surgery, permitting a faster return to normal activities.http://dx.doi.org/10.1155/2018/6423895 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gaetano Gallo Massimiliano Mistrangelo Roberto Passera Valentina Testa Mauro Pozzo Roberto Perinotti Ivan Lanati Ivano Lazzari Paolo Tonello Elettra Ugliono Emilia De Luca Alberto Realis Luc Giuseppe Clerico Mario Trompetto |
spellingShingle |
Gaetano Gallo Massimiliano Mistrangelo Roberto Passera Valentina Testa Mauro Pozzo Roberto Perinotti Ivan Lanati Ivano Lazzari Paolo Tonello Elettra Ugliono Emilia De Luca Alberto Realis Luc Giuseppe Clerico Mario Trompetto Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study Gastroenterology Research and Practice |
author_facet |
Gaetano Gallo Massimiliano Mistrangelo Roberto Passera Valentina Testa Mauro Pozzo Roberto Perinotti Ivan Lanati Ivano Lazzari Paolo Tonello Elettra Ugliono Emilia De Luca Alberto Realis Luc Giuseppe Clerico Mario Trompetto |
author_sort |
Gaetano Gallo |
title |
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study |
title_short |
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study |
title_full |
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study |
title_fullStr |
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study |
title_full_unstemmed |
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study |
title_sort |
efficacy of mesoglycan in pain control after excisional hemorrhoidectomy: a pilot comparative prospective multicenter study |
publisher |
Hindawi Limited |
series |
Gastroenterology Research and Practice |
issn |
1687-6121 1687-630X |
publishDate |
2018-01-01 |
description |
Introduction. Various pain management strategies for patients undergoing open excisional hemorrhoidectomy have been proposed, yet postoperative pain remains a frequent complaint. Objective. To determine whether mesoglycan (30 mg two vials i.m. once/day for the first 5 days postoperative, followed by 50 mg 1 oral tablet twice/day for 30 days) would reduce the edema of the mucocutaneous bridges and thus improve postoperative pain symptoms. Patients and Methods. For this prospective observational multicenter study, 101 patients undergoing excisional diathermy hemorrhoidectomy for III-IV degree hemorrhoidal disease were enrolled at 5 colorectal referral centers. Patients were assigned to receive either mesoglycan (study group SG) or a recommended oral dose of ketorolac tromethamine of 10 mg every 4–6 hours, not exceeding 40 mg per day and not exceeding 5 postoperative days according to the indications for short-term management of moderate/severe acute postoperative pain, plus stool softeners (control group CG). Results. Postoperative thrombosis (SG 1/48 versus CG 5/45) (p<0.001) and pain after rectal examination (p<0.001) were significantly reduced at 7–10 days after surgery in the mesoglycan-treated group, permitting a faster return to work (p<0.001); however, in the same group, the incidence of postoperative bleeding, considered relevant when needing a readmission or an unexpected outpatient visit, was higher, possibly owing to the drug’s antithrombotic properties. Conclusions. The administration of mesoglycan after an open diathermy excisional hemorrhoidectomy can reduce postoperative thrombosis and pain at 7–10 days after surgery, permitting a faster return to normal activities. |
url |
http://dx.doi.org/10.1155/2018/6423895 |
work_keys_str_mv |
AT gaetanogallo efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT massimilianomistrangelo efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT robertopassera efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT valentinatesta efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT mauropozzo efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT robertoperinotti efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT ivanlanati efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT ivanolazzari efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT paolotonello efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT elettraugliono efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT emiliadeluca efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT albertorealisluc efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT giuseppeclerico efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy AT mariotrompetto efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy |
_version_ |
1725715994237730816 |